ATP citrate-lyase

CAT # Izina ryibicuruzwa Ibisobanuro
CPD3611 SB-204990 SB-204990 ni prodrug ya ATP citrate-lyase inhibitor SB-201076. SB-204990, iyo yatanzwe mu kanwa ku mbeba, yinjiye mu kuzenguruka kwa sisitemu, ubushakashatsi bwa farumasi bwa SB-201076 bwagaruwe mu mwijima. SB-204990 (25 mg / kg kumunsi) yanagabanije urugero rwa cholesterol ya plasma (kugeza kuri 23%) hamwe na triglyceride (kugeza kuri 38%) mu mbwa, cyane cyane igabanya lipoproteine ​​nkeya cyane ugereranije na cholesterol ya lipoprotein nyinshi. urwego. SB-204990 ni enzyme yingenzi mugucunga itangwa rya substrate ya lipid synthesis de novo hamwe nintego ya enzyme ishobora guterwa na hypolipidaemic.
Ese?

Twandikire

Itohoza

Amakuru agezweho

  • Inzira 7 Zambere Mubushakashatsi bwa Farumasi Muri 2018

    Inzira 7 Zambere Mubushakashatsi bwa Farumasi I ...

    Kuba uri munsi yigitutu cyinshi kugirango duhatane mubibazo bitoroshye byubukungu n’ikoranabuhanga, uruganda rukora imiti n’ibinyabuzima rugomba guhora rushya muri gahunda zabo za R&D kugirango rukomeze imbere ...

  • ARS-1620: Kanseri nshya ya KRAS-mutant

    ARS-1620: Inhibitor nshya itanga ikizere kuri K ...

    Nk’uko ubushakashatsi bwasohotse mu Kagari bubitangaza, abashakashatsi bakoze inzitizi yihariye ya KRASG12C yitwa ARS-1602 itera ibibyimba gusubira mu mbeba. "Ubu bushakashatsi butanga muri vivo ibimenyetso byerekana ko mutant KRAS ishobora kuba ...

  • AstraZeneca yakira imbaraga zo kugenzura imiti ya oncology

    AstraZeneca yakira imbaraga zo kugenzura ...

    Ku wa kabiri, AstraZeneca yakiriye inshuro ebyiri mu nshingano zayo za oncology, nyuma y’uko abagenzuzi b’Amerika n’Uburayi bemeye gutanga amabwiriza agenga imiti y’ibiyobyabwenge, intambwe yambere yo gutsindira kwemerwa niyi miti. ...

Ikiganiro cya WhatsApp Kumurongo!